EUVIMEDEUVIMED entdecken
Open Access

PSMD2-Mediated MAPK Signaling Promotes Bladder Cancer Development and Immune Microenvironment Remodeling

Shuwen Sun, Jingcheng Zhang, Zongtai Zheng, Yajuan Hao, Tianyuan Xu, Ji Liu, Liang Sun, Aimin Wang, Yadong Guo, Shiyu Mao, Xu Zhang, Yunfei Xu und 2 weitere

Oncology Research · 2025

DOI: 10.32604/or.2025.072373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Shuwen Sun und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Urinary Bladder Neoplasms, MAP Kinase Signaling System, Proteasome Endopeptidase Complex. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Bladder cancer (BCa) progression is closely linked to the immune microenvironment. However, the key molecules that regulate this microenvironment and their specific mechanisms remain poorly understood. This study aims to identify a key molecule and elucidate its mechanisms, providing a theoretical basis for identifying novel therapeutic targets.

Methods

Immune microenvironment-related genes in BCa were identified using The Cancer Genome Atlas and Shanghai Tenth People's Hospital datasets. Proteasome 26S subunit non-ATPase 2 (PSMD2) expression was validated via quantitative polymerase chain reaction (qPCR), Western blot (WB) analysis, and immunofluorescence (IF). In vitro and in vivo experiments confirmed the role of PSMD2 in cell proliferation, invasion, and migration. Kyoto encyclopedia of genes and genomes (KEGG) and Gene Ontology (GO) analyses were conducted to assess PSMD2's influence on immune microenvironment remodeling. A pathomics model predicted PSMD2 expression in patients with BCa.

Results

PSMD2 was identified as a critical factor in BCa, with high expression correlating with poor prognosis and tumor progression. Mechanistically, PSMD2 enhances malignancy by promoting mitogen-activated protein kinase kinase (MEK) and extracellular signal-regulated kinase (ERK) phosphorylation within the mitogen-activated protein kinase (MAPK) signaling pathway. Combined bioinformatics and experimental analyses reveal that PSMD2 downregulates chemokine (C-X-C motif) ligand 14 (CXCL14) expression and secretion via the MAPK pathway, thereby remodeling the immune microenvironment and driving tumor progression. Pathomics analysis further supports the potential of PSMD2 expression as a predictive marker in BCa tissues.

Conclusion

PSMD2 is overexpressed in BCa and significantly correlates with poor prognosis and tumor progression. It promotes malignant development and immune microenvironment remodeling through the MAPK pathway. Pathological analysis can predict PSMD2 expression, offering valuable insights into immunotherapy responses and survival outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentUrinary Bladder NeoplasmsMAP Kinase Signaling SystemProteasome Endopeptidase ComplexHumansAnimalsCell ProliferationPrognosisGene Expression Regulation, NeoplasticMiceCell Line, TumorCell Movement

Stichwörter der Autor:innen

Bladder cancer (BCa)C-X-C motif chemokine ligand 14 (CXCL14)immune infiltrationproteasome 26S subunit non-ATPase 2 (PSMD2)

Substanzen

Proteasome Endopeptidase Complex

Autor:innen und Institutionen

  • Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China.
  • Department of Urology, Bengbu First People's Hospital, Bengbu, 233000, China.
  • Urologic Cancer Institute, School of Medicine, Tongji University, Shanghai, 200072, China.
  • Department of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China.
  • Department of Urology, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, 510317, China.
  • Bio-X Institutes (Key Laboratory for the Genetics of Development and Neuropsychiatric Disorders), Shanghai Jiao Tong University, Shanghai, 200240, China.

Zitieren

APA

Sun, S., Zhang, J., Zheng, Z., Hao, Y., Xu, T., Liu, J., Sun, L., Wang, A., Guo, Y., Mao, S., Zhang, X., Xu, Y., Chen, Y., & Yan, Y. (2025). PSMD2-Mediated MAPK Signaling Promotes Bladder Cancer Development and Immune Microenvironment Remodeling. Oncology Research. https://doi.org/10.32604/or.2025.072373

Vancouver

Sun S, Zhang J, Zheng Z, Hao Y, Xu T, Liu J, et al. PSMD2-Mediated MAPK Signaling Promotes Bladder Cancer Development and Immune Microenvironment Remodeling. Oncology Research. 2025. doi:10.32604/or.2025.072373

BibTeX
@article{Sun2025,
  author = {Sun, Shuwen and Zhang, Jingcheng and Zheng, Zongtai and Hao, Yajuan and Xu, Tianyuan and Liu, Ji and Sun, Liang and Wang, Aimin and Guo, Yadong and Mao, Shiyu and Zhang, Xu and Xu, Yunfei and Chen, Yifan and Yan, Yang},
  title = {PSMD2-Mediated MAPK Signaling Promotes Bladder Cancer Development and Immune Microenvironment Remodeling},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2025.072373}
}
Kostenlos starten →